ZUG, Switzerland: Swiss manufacturer vVARDIS has raised an additional US$50 million (€43 million*) in funding from global healthcare investor OrbiMed, bringing the total capital secured to US$85 million. The financing will support the company’s continued expansion of its minimally invasive product line and commercial operations worldwide.